Jacquelyn Sumer - Mar 15, 2022 Form 4 Insider Report for GENOCEA BIOSCIENCES, INC. (GNCA)

Role
CHIEF LEGAL & COMPLIANCE OFF
Signature
/s/ Diantha Duvall, Attorney-in-Fact for Jacquelyn Sumer
Stock symbol
GNCA
Transactions as of
Mar 15, 2022
Transactions value $
$0
Form type
4
Date filed
3/17/2022, 04:17 PM
Next filing
Jun 2, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GNCA Common Stock Award $0 +37.5K +468.75% $0.00 45.5K Mar 15, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GNCA Stock Option (Right to Buy) Award $0 +113K $0.00 113K Mar 15, 2022 Common Stock 113K $1.11 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units that represent the contingent right to receive, at settlement, one share of common stock. The restricted stock units are scheduled to vest 25% on each of the first four anniversaries of the grant date.
F2 The options are scheduled to vest in 48 equal monthly installments beginning on the first monthly anniversary of the grant date.